November 22, 2022

Dermavant Launches First Commercial for VTAMA® (tapinarof) cream, 1% as Part of a National, Multimedia Campaign for Adults with Plaque Psoriasis

READ MORE

November 8, 2022

Dermavant Announces Highly Favorable Results from Pediatric Maximal Usage Study of VTAMA® (tapinarof) cream, 1% in Atopic Dermatitis

READ MORE

October 13, 2022

Dermavant to Present Data from Multiple Clinical Trials of VTAMA® (tapinarof) cream, 1% at the 2022 Fall Clinical Dermatology Conference

READ MORE

September 7, 2022

Fortune and Great Place to Work® Name Dermavant One of the Best Small Workplaces and Best Workplaces in Biopharma in 2022

READ MORE

August 24, 2022

Dermavant to Present New Data from Phase 3 Trial Program of VTAMA® (tapinarof) cream, 1% for Adults with Plaque Psoriasis at the 2022 EADV Congress

READ MORE

June 28, 2022

VTAMA® (tapinarof) cream, 1% PSOARING 3 Final Data Published in JAAD

READ MORE